Rule 857 IAC 2-3 - Formulary
- Section 857 IAC 2-3-1 - Adrenergic agonists (Repealed)
- Section 857 IAC 2-3-2 - Anesthetics (Repealed)
- Section 857 IAC 2-3-3 - Antibacterials (Repealed)
- Section 857 IAC 2-3-4 - Antihistamines; mast cell stabilizers; decongestant agents (Repealed)
- Section 857 IAC 2-3-5 - Anti-inflammatory agents (Repealed)
- Section 857 IAC 2-3-6 - Antivirals (Repealed)
- Section 857 IAC 2-3-7 - Beta adrenergic blocking agents (Repealed)
- Section 857 IAC 2-3-8 - Carbonic anhydrase inhibitors (Repealed)
- Section 857 IAC 2-3-9 - Direct acting cholinergic agents (Repealed)
- Section 857 IAC 2-3-10 - Hyperosmotic agents (Repealed)
- Section 857 IAC 2-3-11 - Mydriatics and cycloplegics (Repealed)
- Section 857 IAC 2-3-12 - Ocular lubrication; tear testing agents (Repealed)
- Section 857 IAC 2-3-13 - Ophthalmic dyes (Repealed)
- Section 857 IAC 2-3-14 - Combination drugs (Repealed)
- Section 857 IAC 2-3-15 - Nonsteroidal anti-inflammatory agents (Repealed)
- Section 857 IAC 2-3-16 - Formulary of legend drugs (Transferred)
- Section 857 IAC 2-3-17 - Patient's physician notification (Transferred)